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a b s t r a c t
Respiratory syncytial virus (RSV) is a negative-strand RNA virus that is an important cause of
bronchiolitis and pneumonia. We investigated the effect of RSV infection on the expression patterns
of cellular proteins involved in regulating mRNA translation and degradation, and found that a
processing-body protein involved in mRNA degradation, decapping protein 1a (DCP1), was phosphory-
lated rapidly following infection. UV-inactivated and sucrose-puriﬁed RSV were sufﬁcient to mediate
DCP1 phosphorylation, indicating that it occurs as a consequence of an early event in RSV infection.
Analysis using kinase inhibitors showed that RSV-induced DCP1 phosphorylation occurred through the
ERK1/2 pathway. The DCP1 phosphorylation sites were limited to serine 315, serine 319, and threonine
321. Overexpression of wt DCP1 led to a decrease in RSV-induced IL-8 production, but this effect was
abrogated in cells overexpressing phosphorylation-deﬁcient DCP1 mutants. These results suggest that
DCP1 phosphorylation modulates the host chemokine response to RSV infection.
& 2015 Elsevier Inc. All rights reserved.
Introduction
RSV is one of the leading causes of pneumonia-related deaths in
infants, the elderly, and immunocompromised persons worldwide. It
has been estimated that between 75,000 and 125,000 infants in the
United States are hospitalized annually with RSV infection, account-
ing for approximately 25% of pediatric pneumonia and up to 70% of
pediatric bronchiolitis hospitalizations (Welliver, 2003). The global
burden of RSV in young children is approximately 34 million cases
and up to 199,000 deaths per year (Nair et al., 2010). Unfortunately,
there are currently neither vaccines nor effective treatments for
the virus.
Immune responses to RSV are characterized by signiﬁcant inﬂam-
mation that can contribute to disease pathogenesis, particularly
when bronchioles and airways become clogged with cells, debris,
and ﬂuids. RSV infection induces the secretion of several chemokines,
including RANTES, MIP-1α, MIP-1β, IL-8, and fractalkine (Zhang et al.,
2001), which recruit large numbers of immune cells to the sites of
infection. IL-8 recruits neutrophils, which are the dominant cells
found in the bronchial lavage and nasopharyngeal secretions of
infants hospitalized for RSV disease (Everard et al., 1994). Neutrophils
are important for RSV clearance, but they also cause signiﬁcant cell
damage (Mastronarde et al., 1996; Wang et al., 1998), and granulo-
cytes recruited to airways can directly mediate the destruction of
infected cells (Wang et al., 1998).
RSV is a negative-sense RNA virus in the family Paramyxoviridae.
RSV enters host cells via macropinocytosis and acid-independent
membrane fusion (Krzyzaniak et al., 2013). The viral nucleocapsid,
consisting of viral RNA encapsidated with nucleoprotein (N) and
associated with polymerase proteins, is released into the cytoplasm
where the viral RNA-dependent, RNA polymerase performs both
transcription to produce viral mRNAs and replication to generate
antigenome and genome (Collins et al., 2013). The production of new
genomes results in the formation of large cytoplasmic inclusion
bodies containing viral nucleocapsids (Fricke et al., 2013; Garcia
et al., 1993). At later stages in the infection cycle, nucleocapsids are
transported to the plasma membrane where they assemble with
other viral proteins and are released by budding (Collins et al., 2013).
A number of studies have demonstrated relationships between
viruses and various cellular proteins and granular structures involved
in mRNA processing (Lloyd 2012, 2013; Pattnaik and Dinh, 2013;
Reineke and Lloyd, 2013). A signiﬁcant portion of this work has
focused on two inter-related cytoplasmic ribonucleoprotein granules:
stress granules and processing bodies (P-bodies). Stress granules
are rapidly induced in response to cellular stress and are comprised
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of stalled translation-initiation complexes that correlate with transla-
tional shut-off (Anderson, 2008). These granules are believed to be
involved in mRNA triage and storage during stress conditions
(Anderson, 2008). We have previously shown that RSV suppresses
stress–granule formation (Hanley et al., 2010). It has also been shown
that efﬁcient RSV replication depends on a stress granule protein,
G3BP (Lindquist et al., 2010), so it is possible that repressing stress
granule formation might aid RSV replication both by enabling efﬁcient
viral protein expression and maintaining free G3BP. The mechanism
by which RSV represses stress granule formation is unknown, but
appears to involve a non-translated promoter region in the RSV
genome called the trailer (Hanley et al., 2010), as well as inhibition
of PKR activity by the viral N protein (Groskreutz et al., 2010). P-bodies
are cytoplasmic granules believed to be involved in nonsense-
mediated mRNA decay and the microRNA gene-silencing pathway
(Eulalio et al., 2007). They are constitutively present in the cytoplasm
of most cells; however, their distribution can become altered during
stress conditions (Aizer et al., 2013; Rzeczkowski et al., 2011). P-bodies
contain proteins involved in the 5´–3´ mRNA degradation pathway,
including decapping protein 1 (DCP1), a requisite mRNA-decapping
cofactor (Parker and Song 2004).
Initially, we set out to investigate the effect of RSV infection on the
expression levels of stress–granule and P-body proteins as a means to
help determine the mechanism by which stress–granule formation is
inhibited. Most of the proteins we examined showed no change in
expression following RSV infection and did not provide insight into
stress granule inhibition. However, we found that exposure of cells to
RSV resulted in rapid phosphorylation of DCP1. A relationship between
RSV and DCP1 has not been previously characterized. Here we des-
cribe the process by which DCP1 becomes phosphorylated and show
that this modiﬁcation tempers the IL-8 response to RSV infection.
Results
RSV infection resulted in the phosphorylation of DCP1
In a previous study we showed that RSV is able to interfere
with the formation of stress granules (Hanley et al., 2010),
indicating that there is an interaction between RSV and cellular
RNA pathways involved in RNA stability. To follow up on this
ﬁnding, we investigated whether RSV has a detectable effect on
the abundance of proteins involved in post-transcriptional control.
HEp-2 cells were mock infected or infected with increasing doses
of RSV. Eighteen hours after infection, cell lysates were harvested
and analyzed using Western blot analysis with antibodies toward a
selection of stress granule and P-body-associated proteins. As a
comparison, cells were treated with arsenite, an inducer of
oxidative stress, for 30 min prior to harvest and analysis. As shown
in Fig. 1A, neither the levels nor migration patterns of DCP2, EDC3,
EDC4, eIF3, Xrn1, TIAR, TIA-1, eIF3, or G3BP were altered either
following infection with RSV or arsenite treatment. In contrast, the
electrophoretic mobility and abundance of DCP1 was altered in
RSV-infected cells. In mock-infected cells, DCP1 migrated as a
doublet (Fig. 1A, top panel, lane 1); however, in arsenite-treated
cells (lane 2) or cells infected with RSV at an moi of 1 or 5 (lanes
5 and 6, respectively), DCP1 migrated as only the upper band (the
migration shift can also been seen more clearly in panel C). In
addition, the abundance of DCP1 was increased in these cells.
These results indicate that RSV has a dose-dependent effect on
DCP1 expression and modiﬁcation. To determine whether RSV
infection results in an altered DCP1 migration pattern and abun-
dance in another cell type, we analyzed DCP1 expression in RSV
infected A549 cells and obtained similar results, demonstrating
that this was not a cell speciﬁc phenomenon (Fig. 1B). In all the
following experiments we used HEp-2 cells (an epithelial cell line
that supports efﬁcient RSV replication). The reason for this is that
we were able to achieve higher transfection efﬁciency in HEp-2
than A549 cells, which was essential for subsequent experiments
in this study.
A number of studies have shown that a variety of cellular changes,
including arsenite-induced oxidative stress, can cause DCP1 to
become phosphorylated. To determine if the change in DCP1 migra-
tion observed during RSV infection was due to phosphorylation, we
assessed whether DCP1 migration was altered by phosphatase
treatment. HEp-2 cells were mock infected, treated with sodium
arsenite (as a positive control for DCP1 phosphorylation), or infected
with RSV. Cell lysates were then either mock treated or treated with
λ-phosphatase, which dephosphorylates serine, threonine, and tyr-
osine residues. Samples were analyzed by Western blotting with a
DCP1 speciﬁc antibody (Fig. 1C). Cell lysates that were mock treated
with phosphatase showed a similar DCP1 migration pattern as in
Fig. 1A and B: DCP1 from mock-infected cells migrated as a doublet
(Fig. 1C, lane1), while DCP1 from arsenite-treated and RSV-infected
cells migrated as only the upper band (Fig. 1C, lanes 3 and 5). In
contrast, DCP1 from each sample that was treated with phosphatase
migrated slightly more rapidly than the lower band from mock-
infected cells (Fig. 1C, lanes 2, 4, and 6). These results show that DCP1
is present in both hypo- and hyperphosphorylated forms in mock
infected HEp-2 cells and that in response to RSV, the hyperpho-
sphorylated form (upper band) is dominant. Thus, RSV infection
results in the phosphorylation of DCP1.
DCP1 was phosphorylated early in response to exposure to RSV, but
independently of viral replication
The virus stock that was used to perform the experiments shown
in Fig. 1 consisted of clariﬁed supernatant from RSV-infected cells. The
cytokine IL-1α has been shown to induce DCP1 phosphorylation
(Rzeczkowski et al., 2011), raising the possibility that a soluble factor
released from the cells used to generate the virus stock could be
responsible for inducing DCP1 phosphorylation, rather than RSV
per se. Therefore, we compared the effect of exposing cells to
unpuriﬁed RSV versus RSV that had been puriﬁed onto a sucrose
cushion. In both cases, a time course was performed to examine the
kinetics of DCP1 phosphorylation. HEp-2 cells were exposed to RSV
for varying lengths of time, from 15min to 24 h. Cell lysates were
harvested, and DCP1 was examined by Western blot analysis. DCP1
was phosphorylated within 15 min of exposure to RSV, and remained
phosphorylated throughout infection with both unpuriﬁed and
sucrose-puriﬁed RSV (Fig. 2A, top two panels). Because stressors,
including osmotic stress, have been shown to affect DCP1 phosphor-
ylation (Rzeczkowski et al., 2011), a control was performed to conﬁrm
that the sucrose that would be present in sucrose-puriﬁed RSV had no
effect. To accomplish this, sucrose was added to cell culture medium
at an equivalent concentration as in the sucrose-puriﬁed RSV. This
treatment had no detectable effect on DCP1 phosphorylation (data
not shown). These results suggest that DCP1 phosphorylation was
triggered by an early event in RSV infection, and that RSV alone was
sufﬁcient to mediate the effect, independently of soluble factors that
might have been present in the virus inoculum. To determine
whether RSV replication is necessary for DCP1 phosphorylation, the
time course described above was also performed with UV-inactivated
unpuriﬁed or sucrose-puriﬁed RSV (Fig. 2A, lower two panels). Cells
treated with UV-inactivated RSV showed a transient increase in DCP1
phosphorylation, corresponding with the time frame that virus was in
contact with cells (Fig. 2A, lower two panels, lanes 2–4). Once the
media was replaced, the band of hypophosphoryated DCP1 reap-
peared (Fig. 2A, lower two panels, lanes 5–7); however, the upper
band remained dominant, distinguishing cells exposed to RSV from
mock-infected cells (compare lanes 1 and 7). These results indicate
that DCP1 may become phosphorylated independently of RSV
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replication, but that RSV replication was necessary to maintain DCP1
in a near-completely hyperphosphorylated state throughout infection.
Cytokines released from RSV-infected cells also caused
phosphorylation of DCP1
Although the experiment shown in Fig. 2A demonstrated that RSV
alone was sufﬁcient to cause DCP1 phosphorylation, these results did
not exclude the possibility that factors secreted by infected cells could
also have an effect. To determine whether factors in the supernatant
(other than RSV) were able to induce DCP1 phosphorylation, the
supernatant from RSV-infected cells was subjected to ultra-high
velocity centrifugation to pellet the virus. The supernatant fraction
was collected and was found to have minimal residual virus (80 and
150 pfu/ml, in two independent experiments). HEp-2 cells were mock
treated, treated with supernatant from RSV-infected cells, or incubated
with puriﬁed RSV as a control. At 1 h post treatment or infection, cells
were either harvested directly, or the medium was replaced and the
cells were harvested at 18 h post treatment, and the samples were
analyzed as described above. Analysis of cell lysates collected at 1 h
post treatment showed that while DCP1 from mock-infected cells
migrated as a doublet, DCP1 from cells treated with supernatant
migrated primarily as the upper band, similarly to DCP1 from cells
infected with RSV (Fig. 2B, upper panel). In contrast, in samples
collected at 18 h post treatment, DCP1 in supernatant-treated cells
migrated as a doublet, similarly to mock infected cells (Fig. 2B, lower
panel). These results indicate that one or more soluble factors released
into the supernatant of RSV-infected cells was able to mediate DCP1
phosphorylation; however, the effect was transient, in contrast to RSV
infection-mediated DCP1 phosphorylation.
RSV infection of epithelial cells in vitro results in induction of a
large number of cytokines, which could be the soluble factors
responsible for stimulating DCP1 phosphorylation in the experiment
shown in Fig. 2B (upper panel). To test this possibility, we examined
the effects of three cytokines shown previously to be released by RSV
infected epithelial cells cultured in vitro: IL-1β, TNF-α (Patel et al.,
1995), and IFN-α (Hornung et al., 2004; Jewell et al., 2007). Cells were
treated with varying concentrations of IL-1β, TNF-α, or IFN-α for one
hour, then lysed and assessed for DCP1 phosphorylation. As shown in
Fig. 2C, DCP1 was phosphorylated in response to all tested concentra-
tions of IL-1β and TNF-α. In contrast, treatment with IFN-α did not
result in DCP1 phosphorylation at any of the concentrations tested.
This result shows that some, but not all, cytokines can stimulate DCP1
phosphorylation. Together with the data presented in Fig. 2A, these
results indicate that RSV infection results in DCP1 phosphorylation
through two paths: ﬁrst through a direct response of the cell to virus
exposure, and second as a response of the cell to some of the
cytokines released as a consequence of RSV infection.
RSV infection resulted in decreased localization of DCP1 to P-bodies
Others have shown that DCP1 phosphorylation correlates with
changes in P-body distribution and number. However, these effects
appear to be highly complex, with different inducers of DCP1
phosphorylation resulting in widely different outcomes (Aizer et al.,
2013; Rzeczkowski et al., 2011). Therefore, we assessed whether RSV
infection altered the subcellular location of DCP1. HEp-2 cells were
mock infected or infected with RSV. At various times post infection,
cells were ﬁxed and examined using immunoﬂuorescence (Fig. 3).
DCP1 in mock-infected cells appeared in numerous small, cytoplasmic
puncta, characteristic of P-bodies, with an average of 15.571.22 SEM
DCP1-containing puncta per cell. The number of DCP1-containing
puncta in cells infected with RSV was similar to that in mock-infected
cells early during infection; however, later in infection the number of
DCP1-containing puncta was signiﬁcantly decreased, with means of
8.670.97 and 6.870.96 puncta per cell at 12 and 24 h post infection,
respectively. These results suggest that RSV infection may alter DCP1
inclusion in P-bodies late in infection; however there was no obvious
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Fig. 1. Exposure of cells to RSV results in phosphorylation of DCP1. (A and B) HEp-2 (A) or A549 cells (B) were mock infected, treated with 0.5 mM sodium arsenite for 30 min
(ars.), or infected with RSV at an moi of 0.01 to 10 pfu/cell, as indicated. 18 h post infection, cells were lysed and soluble fractions of samples were assessed by Western blot
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L.L. Dickey et al. / Virology 481 (2015) 199–209 201
correlation between the change in the phosphorylation status of DCP1
and P-body distribution or number.
DCP1 was phosphorylated by the ERK1/2 pathway following exposure
of cells to RSV
Having found that DCP1 was phosphorylated rapidly following
exposure of cells to RSV, we sought to determine which kinase
pathway was responsible. Previous studies have demonstrated JNK
(Rzeczkowski et al., 2011) and/or ERK2 (Chiang et al., 2013) pathway
involvement in DCP1 phosphorylation under various conditions. Both
JNK and ERK1/2 are mitogen-activated protein kinases (MAPKs) that
become activated in response to stress. To examine whether known
MAPK pathways were responsible for RSV-mediated DCP1 phosphor-
ylation, we assessed whether MAPK activation correlated temporally
with DCP1 phosphorylation during RSV infection. HEp-2 cells were
mock infected or infected with sucrose-puriﬁed RSV. Cells were
harvested at a range of time points from 5min to 24 h post infection,
and ERK1/2, JNK, p38 and ERK 5 activation were assessed using
Western blot analysis with antibodies speciﬁc to total or phosphory-
lated MAPK proteins. Phosphorylation of DCP1 was also assessed as
described above. As a control, uninfected cells were treated with
arsenite for 30 min prior to harvest. As shown in Fig. 4A, all MAPKs
were activated in response to arsenite, conﬁrming the sensitivity of
the phosphoprotein-speciﬁc antibodies. In contrast, the MAPKs were
differentially activated in response to RSV. Increased ERK1/2 activation
occurred within 5 min of RSV infection and ERK1/2 remained acti-
vated throughout infection, consistent with previously published data
(Chen et al., 2000). The extent of ERK1/2 activation during RSV
infection was greater than observed following arsenite treatment. A
low level of p38 phosphorylation was detectable at 5 and 15min post
infection, but returned to baseline activation thereafter. JNK and ERK5
did not show signiﬁcant levels of phosphorylation during infection.
These results identiﬁed ERK1/2 as the most likely MAPK responsible
for RSV-mediated DCP1 phosphorylation.
To conﬁrm if ERK1/2 was responsible for RSV-mediated DCP1
phosphorylation, we examined the effect of treating cells with a panel
of pharmacological MAPK inhibitors (Fig. 4B). 5Z-7-oxozeanol has
been demonstrated to strongly inhibit MKKK TAK1, and thereby
repress ERK1/2, JNK, and p38 activation (Lee et al., 2000; Ear et al.,
2010; Sato et al., 2005). Both U0126 and PD98059 inhibit both MEK1
and MEK5, and thereby inhibit activation of ERK1/2 and ERK5 (Davies
et al., 2000). PD184352 inhibits both ERK1/2 and ERK5 at 20 mM, but
only ERK1/2 at 2 mM (Davies et al., 2000). SB203580 speciﬁcally
inhibits p38 activation (Davies et al., 2000). SP600125 is relatively
non-speciﬁc, but strongly inhibits JNK activation (Davies
et al., 2000; Tanemura et al., 2009). HEp-2 cells were mock treated
with DMSO or treated with the indicated inhibitor. One hour after
treatment, cells were mock infected or infected with RSV in the
presence of the inhibitors. One hour post infection, cells were lysed
and DCP1, phosphorylated ERK1/2, and total ERK1/2 were assessed by
Western blot analysis. This analysis showed that RSV-induced ERK1/2
activation was blocked by 5Z-7-oxozeanol, U0126, and PD184352, as
expected (Fig. 4C, top panel, compare lane 3 with lanes 4, 5, 7, and 8).
In contrast, treatment of cells with SB203580 and SP600125 did not
inhibit ERK1/2 activation, and treatment with PD98059 had an
intermediate effect (Fig. 4C, top panel, lanes 9, 10 and 6, respectively).
Examination of DCP1 showed that treatment of RSV infected cells with
inhibitors that reduced activation of ERK1/2 resulted in DCP1 migrat-
ing as a doublet, similarly to mock infected cells (Fig. 4C, third panel,
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compare lane 1 with lanes 4-8, panel 4D). This indicates that the
ERK1/2 pathway is responsible for DCP1 phosphorylation during RSV
infection. In contrast, DCP1 from RSV-infected cells pretreated with
SB203580 (Fig. 4C, third panel, lane 9) or SP600125 (Fig. 4C, third
panel, lane 10) migrated as the upper phosphorylated band, indicating
that neither JNK nor p38 was involved in RSV-mediated DCP1 phos-
phorylation (Fig. 4D). These results conﬁrm that DCP1 phosphoryla-
tion is modulated by MAPK pathways and demonstrate that activation
of the ERK1/2 pathway is required for DCP1 to become phosphory-
lated following cell exposure to RSV.
DCP1 was phosphorylated at S315, S319 and T321 during RSV
infection
Other studies have identiﬁed three potential phosphorylation
sites on DCP1: S315, S319 and T321 (Aizer et al., 2013; Rzeczkowski
h 2 ,VSRkcom
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Fig. 3. Effect of RSV infection on P-body distribution. HEp-2 cells were mock infected or infected with RSV at an moi of 5. Cells were ﬁxed at the indicated time post infection
and analyzed using immunoﬂuorescence with antibodies toward DCP1 (green) and RSV N protein (red). Cells were also stained with DAPI to visualize nuclei. Results are
representative of two independent experiments.
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et al., 2011; Blumenthal et al., 2009). To investigate whether these
sites were phosphorylated in response to RSV infection, expression
plasmids were generated that contained DDK-tagged DCP1 inwhich
S315, S319, and T321 of DCP1 were each individually substituted, or
all substituted (to generate a triple mutant), with alanine. HEp-2
cells were transiently transfected with each of the plasmids and
subsequently infected with RSV for 24 h. DCP1 phosphorylation and
RSV protein expression were assessed by Western blot analysis. The
different forms of DCP1 were somewhat difﬁcult to discern using
the anti-DCP1 antibody because this antibody detected both the
hypo- and hyperphosphorylated forms of both endogenous and
plasmid-expressed DCP1, which all migrated close to one another;
however, this analysis showed that DDK-DCP1 was efﬁciently
expressed compared to endogenous DCP1 (Fig. 5A, upper panel,
compare lane 1 with 3, and 2 with 4). Analysis with an anti-DDK
antibody allowed the effects of the substitutions on DCP1 phos-
phorylation to be determined (Fig. 5A, lower panel). Overexpressed
wt DDK-DCP1 showed a similar pattern of phosphorylation as
endogenous DCP1 with DDK-DCP1 migrating as a doublet in lysates
from mock-infected cells, and as a dominant upper band in lysates
from RSV-infected cells. In contrast, S315A DDK-DCP1 had a
different migration pattern in RSV infected cells, with the upper
band migrating more rapidly than that of wt DDK-DCP1, indicating
decreased phosphorylation. The migration patterns of the cells
overexpressing the DCP1 variants S319A or T321Awere also slightly
altered compared to wt DDK-DCP1, indicating decreased phosphor-
ylation. In each case, the lower band was more prominent com-
pared to wt transfected, RSV infected samples, but not as prominent
as in mock-infected cells. These ﬁndings suggest that S315, S319 and
T321 all contributed, to various degrees, to RSV-mediated DCP1
phosphorylation. The triple-DCP1 mutant migrated as only the
lower band of the doublet, both in mock and RSV infected cells,
conﬁrming that the detectable change in wt DCP1 phosphorylation
was entirely due to phosphorylation of S315, S319 and T321.
Collectively, these results demonstrate that RSV-mediated phos-
phorylation is limited to residues S315, S319 and T321 of DCP1.
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DCP1 phosphorylation affected RSV-induced IL-8 production
The ability to overexpress phosphorylation-deﬁcient DCP1 allowed
us to explore the signiﬁcance of DCP1 phosphorylation during RSV
infection. DCP1 phosphorylation has been shown to enhance its
interaction with the decapping enzyme DCP2, which could affect
mRNA decapping and stability (Chiang et al., 2013). Furthermore,
DCP1 phosphorylation has been shown to affect the levels of certain
chemokines produced by cells, in particular IL-8 (Rzeczkowski et al.,
2011). IL-8 is a key chemokine released in response to RSV infection
and can be expressed by epithelial cells. Therefore, we examined the
effect that DCP1 overexpression and phosphorylation had on RSV
protein expression and IL-8 production. HEp-2 cells were mock
transfected with empty vector or transfected with a plasmid expres-
sing GFP, as negative controls, or transfected with wt or mutant DDK-
DCP1. At 24 h post transfection, cells were infected with RSV at moi of
5. Supernatants were collected at 0, 2, 8 and 24 h post infection and
cell lysates were collected at 0 and 24 h post infection. Western blot
analysis of the cell lysates using a DCP1 speciﬁc antibody conﬁrmed
that DDK-DCP1 was signiﬁcantly overexpressed compared to wt DCP1
(Fig. 5B, compare lanes 1, 2 and 7). Analysis using a polyclonal anti-
RSV antibody (Fig. 5B) and quantiﬁcation (not shown) showed that
overexpression of wt or mutant DCP1 did not signiﬁcantly affect RSV
protein expression, indicating that DCP1 does not affect RSV gene
expression or viral replication over a single growth cycle. ELISA
determination of IL-8 protein levels in the supernatant showed that
at 0 and 2 hpi there were only background levels of released IL-8
protein (not shown). However, the levels of secreted IL-8 increased by
8 h post infection, and ampliﬁed signiﬁcantly (more than 20-fold)
between 8 and 24 h post infection. Overexpression of the DCP1
mutants had no detectable effect on the kinetics of the IL-8 response,
but did have a statistically signiﬁcant effect on its magnitude.
Overexpression of wt DCP1, which was present in both a hypo- and
hyperphosphorylated form, resulted in a greater than two-fold
decrease in IL-8 levels at 24 h post infection. This decrease was almost
completely abrogated by the triple-A mutation, which is completely
DCP1 phosphorylation deﬁcient (Fig. 5C). These results demonstrate
that in the context of RSV infection, IL-8 protein expression can be
inhibited by hyperphosphorylated DCP1, indicating a potential role for
DCP1 phosphorylation in chemokine regulation.
Discussion
In this study we have presented novel ﬁndings characterizing the
relationship between RSV and DCP1, a cellular protein involved in
decapping speciﬁc subsets of mRNAs in order to regulate their exp-
ression. We demonstrated that RSV infection leads to both the phosp-
horylation of DCP1 via the ERK1/2 pathway, as well as increased DCP1
expression. Both these effects combine to modulate expression of IL-8.
While DCP1 phosphorylation has been described previously, this
is the ﬁrst time it has been shown to occur in response to viral
infection. As shown in Fig. 2A, DCP1 became phosphorylated within
15 min of exposure of cells to RSV and remained in phosphorylated
form throughout the course of infection. This rapid modiﬁcation
early in infection suggested that DCP1 phosphorylation occurs
independently of virus gene expression, and this was conﬁrmed in
experiments using UV-inactivated RSV. In addition, we demonstrated
that sucrose-puriﬁed RSV stimulated DCP1 phosphorylation to a
similar extent as unpuriﬁed virus. Together, these ﬁndings show that
DCP1 phosphorylation occurs in response to an early event in the
RSV replication cycle, such as attachment, fusion, or cell entry.
Although puriﬁed RSV was sufﬁcient to stimulate DCP1
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Fig. 5. RSV-mediated DCP1 phosphorylation affects RSV induced IL-8 production. (A) Identiﬁcation of DCP1 phosphorylation sites during RSV infection. HEp-2 cells were
transfected with empty vector or constructs expressing wt DDK-tagged DCP1, or DDK-DCP1 in which residues S315, S319, and/or T321 were mutated to alanine. At 24 h post
transfection, cells were infected with RSV (moi of 5), and 24 h post infection cells were harvested. Cell lysates were analyzed by Western blotting with antibodies against
DCP1 or DDK, as indicated. (B) DCP1 does not affect RSV protein expression over a single cycle. HEp-2 cells in duplicate were transiently transfected with constructs
expressing wt DCP1, or DCP1 in which S315, S319, and/or T321 were mutated to alanine residues. Cells were transfected with either empty vector, or vector expressing GFP,
as negative controls. At 24 h post transfection, cells were infected with RSV (moi¼5). At 0 and 24 hpi cells were harvested and analyzed by Western blotting with indicated
antibodies. (C) DCP1 phosphorylation inhibits IL-8 protein expression. Concentrations of secreted IL-8 in the cell supernatants at 8 and 24 h post infection from the
experiment shown in panel B were determined by ELISA. In each experiment, the IL-8 values were normalized to the values obtained with empty vector at 8 and 24 hpi. The
bar chart shows the mean and standard deviation of three (GFP, S315A, S319A and T321A) or four (empty, wt and Triple) independent experiments. Statistical signiﬁcance
was determined using Student's paired T-tests on IL-8 concentration values (*p¼0.0386, **p¼0.0405).
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phosphorylation, we showed that one or more soluble factors might
also contribute to the effect. Exposure of cells to UV-inactivated RSV
resulted in only transient phosphorylation of DCP1, indicating that
viral replication was important for sustaining the response, and we
found that the supernatants of RSV-infected cells (fromwhich almost
all infectious virus was removed) were able to mediate transient
DCP1 phosphorylation (Fig. 2B). These ﬁndings suggest that although
the virus per se can cause DCP1 phosphorylation, factors secreted as
a consequence of RSV replication may contribute to sustained DCP1
phosphorylation during infection. Here we show that two cytokines,
previously shown to be released in response to RSV infection, IL-1β
and TNF-α were able to elicit DCP1 phosphorylation in HEp-2 cells
(Fig. 2C), which could explain why RSV-infected-cell supernatant has
an effect. These ﬁndings indicate that RSV infection of epithelial cells
elicits DCP1 phosphorylation through at least two paths: direct
exposure to the virus itself, and through an indirect effect due to
cytokines that are released in the course of infection. It is likely a
combination of these factors that leads to sustained DCP1 phosphor-
ylation over the infection period.
The pathway responsible for DCP1 phosphorylation, at least
during the initial virus-induced stimulus, was found to be ERK1/2.
Similarly to other groups, we found that ERK1/2 was activated
shortly after exposure of cells to RSV (Chen et al., 2000) and this
activation correlated with DCP1 phosphorylation (Fig. 4A). In addi-
tion, we found that ERK1/2 chemical inhibitors inhibited RSV-
mediated DCP1 phosphorylation (Fig. 4C). RSV also activated p38,
as reported previously (Pazdrak et al., 2002; Singh et al., 2007; Tu et
al., 2007), but JNK was not activated to a detectable level. Impor-
tantly, neither p38 nor JNK inhibitors had a detectable effect on DCP1
phosphorylation (Fig. 4C).
Many studies have shown putative roles for DCP1 phosphorylation,
including regulating neuronal development (Blumenthal et al., 2009),
mitosis (Aizer et al., 2013), oocyte maturation (Ma et al., 2013),
adipocyte differentiation (Chiang et al., 2013), and P-body distribution
(Rzeczkowski et al., 2011). A recent study in mice showed that DCP1
phosphorylation increased its interaction with decapping protein
DCP2, forming a complex necessary for mRNA decapping (Chiang et
al., 2013). DCP1 phosphorylation is also associated with stress-granule
formation and translational arrest in response to oxidative stress
(Blumenthal et al., 2009) and antibiotic treatment (Rzeczkowski et
al., 2011). In addition, a study has shown that overexpression of DCP1
can result in activated PKR, phosphorylated eIF2α, and translational
arrest (Dougherty et al., 2014). Together, these studies indicate that
RSV-induced DCP1 phosphorylation and accumulation could both
function to negatively regulate gene expression. The results presented
in Fig. 5 show that such regulation does occur, but in a gene speciﬁc
manner. Overexpression of neither wt nor phosphorylation mutants of
DCP1 had a consistent detectable effect on RSV protein expression (or
tubulin accumulation; Fig. 5B). In contrast, in three independent
experiments, RSV-induced IL-8 expression was affected. Over-
expression of wt DCP1, in which DCP1 was predominantly present
in the hyper-phosphorylated form (Fig. 5A), inhibited IL-8 expression
compared to either empty vector or GFP control. However, if mutant
DCP1 with any of the three described phosphorylation sites mutated
to alanine was transfected into cells, tilting the DCP1 population
toward the unphosphorylated form, IL-8 expression was partially
restored to levels comparable with the empty vector and GFP controls
(Fig. 5C). RSV infection alone does not induce host-cell translation
inhibition and there is no evidence that RSV has evolved mechanisms
to allow selective translation of viral mRNAs. Thus, these results
suggest that in this experiment, suppression of IL-8 protein secretion
was not due to global translational shut-off, but more likely through a
speciﬁc regulatory mechanism. IL-8 could be regulated directly by the
decapping pathway targeting IL-8 mRNA, but might also be regulated
indirectly. For example, DCP1 phosphorylation has been shown to
affect NFκB expression, and in turn, expression of NFκB responsive
genes (Rzeczkowski et al., 2011). Therefore, additional research will be
required to deﬁne the mechanism by which RSV induced DCP1
phosphorylation affects secretion of IL-8 protein. We focused on IL-8
because previously IL-8 expression had been shown to be affected by
DCP1 phosphorylation (Rzeczkowski et al., 2011), and because IL-8 is
relevant for RSV pathogenesis. We have not investigated the effect of
DCP1 on other RSV-induced chemokines and it would be of interest to
determine if the effect that we observed extends more widely. It
should be noted that the data presented here are in contrast to
ﬁndings by Rzeczkowski and coworkers (Rzeczkowski et al., 2011).
They found that compared to a wt DCP1 control, a phosphorylation-
deﬁcient DCP1 mutant completely blocked all IL-1-induced gene
expression, including IL-8 production. The reason for the discrepancy
between the two studies is unclear; however, there are a number of
differences between our experiments, with key differences being the
inducer (RSV versus IL-1), the kinase pathway involved (ERK1/2 versus
JNK), and the magnitude of the IL-8 response (45,000 pg/ml
following 24 h infection with RSV versus 750 pg/ml following 8 h
treatment with IL-1).
In our experiments, there was no detectable change in P-body
size or distribution until late stages of RSV infection, suggesting
that DCP1 phosphorylation did not affect P-body assembly or
integrity (Fig. 3). This is consistent with previous ﬁndings that
DCP1 depletion with small interfering RNAs has no effect on P-
body size or number (Eulalio et al., 2007). In addition, we found
that DCP1 levels were increased at later times of RSV infection
(Fig. 1), but the reason for this is not known. However, the
different phosphorylation-mutant DCP1 proteins were expressed
at similar levels compared to wt DCP1 (Fig. 5A), indicating that the
increase in the level of DCP1 protein was not a consequence of a
change in DCP1 stability due to it being phosphorylated, but due to
another effect of RSV infection.
RSV is not the only virus to have been shown to have an effect on
DCP1. Poliovirus 3C proteinase has been shown to cleave DCP1 and P-
body proteins XrnI and Pan3 (Dougherty et al., 2011). Cleavage of XrnI
and Pan3 could be of beneﬁt to poliovirus by increasing the stability of
viral RNAs, but the signiﬁcance of DCP1 cleavage for poliovirus is less
clear. As discussed by the authors of this study, it is possible that
disruption of the decapping pathway could have an effect on innate
immune responses. In light of the previous ﬁndings regarding
poliovirus and the results presented here, it is interesting to speculate
whether RSV has evolved to mediate DCP1 phosphorylation during
infection in order to increase its ﬁtness, or whether DCP1 phosphor-
ylation is important for cellular responses to viral infection. Based on
the available evidence, we suggest that DCP1 phosphorylation is an
element of the host response. MAP kinases, including ERK1/2, play an
important role in regulating the innate immune response (Arthur and
Ley, 2013) and there are a number of studies indicating that the ERK1/
2 pathway is key in promoting the innate immune response to RSV
(Pazdrak et al., 2002; Kato et al., 2012; Monick et al., 2005). If the
ERK1/2 pathway is the only kinase pathway responsible for transdu-
cing a signal to stimulate DCP1 phosphorylation during infection, as
suggested by the data shown in Fig. 4C, it seems unlikely that RSV
evolved to stimulate ERK1/2 and DCP1 phosphorylation for its own
beneﬁt, especially given that the phosphorylation status of DCP1 had
no effect on RSV protein expression (Fig. 5B). Rather, it is more likely
that ERK1/2-mediated DCP1 phosphorylation is part of an integrated
cellular response to the invading virus. Experiments testing the effect
of an ERK1/2 inhibitor in RSV infected cells have suggested that the
ERK1/2 pathway is important for stimulating the IL-8 response (Chen
et al., 2000). Activation of the innate immune response through MAPK
pathways also generally involves induction of negative regulatory
loops to limit inﬂammatory damage (Arthur and Ley, 2013). Therefore,
we propose that RSV-induced, ERK1/2-dependent DCP1 phosphoryla-
tion is part of a coordinated cellular response that allows innate
immune responses to be modulated.
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Materials and methods
Cell lines and antibodies
HEp-2 cells (ATCC) were cultured in Opti-MEM with 2% fetal
bovine serum (FBS) (GIBCO-Invitrogen). A549 cells (ATCC) were
cultured in F-12 K medium supplemented with 10% FBS (GIBCO-
Invitrogen). Both cell lines were incubated at 37 1C with 5% CO2.
The following antibodies were used in this study: mouse anti-RSV
nucleoprotein antibody (Serotec), rabbit anti-DCP1 and goat anti-RSV
proteins antibodies (Abcam), goat anti-Xrn1, anti-EDC3, anti-EDC4,
anti-TIAR, and anti-TIA-1 antibodies (Santa Cruz), goat anti-G3BP
antibodies (BD Biosciences), rabbit anti-p44/42 MAPK (ERK1/2), rabbit
anti-phospho-p44/42 MAPK (ERK1/2) (Thr202/Tyr204), rabbit anti-
p38 MAPK, anti-phospho-p38 MAPK (Thr180/Tyr182), rabbit anti-
SAPK/JNK, rabbit anti-phospho-SAPK/JNK (Thr183/Tyr185), rabbit
anti-ERK5, and rabbit anti-phospho-ERK5 (Thr218/Tyr220) antibodies
(Cell Signaling Technology).
RSV stocks
To propagate RSV (strain A2), 80% conﬂuent HEp-2 cells in
150 cm2 ﬂasks were infected with RSV at an moi of 0.01 in 10 ml
Opti-MEMþ2% FBS. One to four h post infection, media were
replaced with 20 ml fresh media. Media was changed every 36–
48 h. Once extensive syncytia formation was observed, cells and
supernatant were collected in 50- ml conical tubes and subjected to
two rounds of vortexing (10 s) and sonication (30 s) to detached cell-
associated virions. The cell suspension was then subjected to cen-
trifugation at 300g at 4 1C for 5 min and supernatant was collected,
ﬂash frozen, and stored at 80 1C. RSV titers were determined by
plaque assay as described previously (Hanley et al., 2010). To sucrose
purify RSV, fresh virus suspensions were pelleted through 30%
sucrose onto a 60% sucrose cushion (sucrose w/v in 10 mM Tris, pH
8.1) by centrifugation at 24,000g for 1 h at 4 1C. The white band at
the 30/60% sucrose interface was collected, diluted 1:10 in OptiMem
supplemented with 50 mM HEPES and 100 mMMgSO4, ﬂash frozen,
and stored at 80 1C. As a control to ensure that the sucrose that
would be present in the puriﬁed virus did not have an effect on DCP1
phosphorylation, 60% sucrose was diluted 1:10 in OptiMem solution
described above, similarly to the sucrose puriﬁed virus, and cells
were treated with an equivalent volume of this sucrose solution as
the volume of sucrose-puriﬁed RSV used for the virus infection. To
prepare RSV-free supernatant, virus suspensions were subjected to
centrifugation at 24,000g for 1 h at 4 1C and samples from the
supernatant fraction were taken. Titers of infectious virus in unpur-
iﬁed and sucrose-puriﬁed RSV and virus-cleared supernatant were
determined by plaque assay as described previously (Hanley et al.,
2010). UV-inactivated virus was generated by exposing virus in 6-
well plates to 200 J/m2, approximately 15 cm from light source. UV-
inactivation of RSV was conﬁrmed by plaque assay. HEp-2 cells or
A549 cells were infected with unpuriﬁed, sucrose puriﬁed, or treated
with UV-inactivated RSV, as described in the ﬁgure legends, for 1-2 h
at 37 1C. Media was changed and cells were incubated at 37 1C for the
times indicated.
Cell harvesting and western blot analysis
Cells were lysed in RIPA buffer (Boston Bioproducts) with
protease inhibitors (Roche) and HALT phosphatase inhibitors
(Roche) according to the manufacturer's instructions, unless other-
wise speciﬁed. Cells were incubated on ice for 10 min, after which
supernatants were collected in microcentrifuge tubes, vortexed,
and subjected to centriguation at 16,000g for 10 min at 4 1C.
Soluble fractions were collected and added to 2 Laemmli buffer
(BioRad) with 0.1 M dithiothreitol. Samples were separated on 10%
SDS polyacrylamide gels, transferred to nitrocellulose membranes,
blocked with either TBS plus 5% milk or Odyssey blocking buffer
(LI-COR) overnight at 4 1C, and probed with appropriate antibo-
dies. Membranes were analyzed either by chemiluminescence
(Western Lighting Chemiluminescence Reagent, Perkin Elmer), or
LI-COR imaging with the LI-COR Odyssey reader. Protein bands
were quantiﬁed using LI-COR Image Studio software.
Phosphatase assay
HEp-2 cells were mock infected, treated with 0.5 mM sodium
arsenite for 30 min immediately prior to harvest, or infected with
RSV (moi¼5). Cells were lysed in RIPA buffer and centrifuged at
16,000g for 10 min at 4 1C. The soluble fraction was collected and
then either mock treated or treated with λ-phosphatase (Santa
Cruz) according to the manufacturer's instructions before being
analyzed by Western blotting, as described above.
Treatment of uninfected cells with cytokines
Monolayers of uninfected HEp-2 cells were treated with 1, 3, or
10 ng/ml of IL-1β or TNF-α (R&D systems), or 10, 30, or 100 U/ml of
IFN- α (PBL). One hour post treatment, cells were lysed in RIPA buffer
containing protease and phosphatase inhibitors, and DCP1 phosphor-
ylation was assessed using Western blot analysis.
Kinase inhibitor assay
80% conﬂuent HEp-2 cells were mock treated with DMSO or
treated with 1 μM 7-oxozeanenol, 1 μM U0126, 20 μM PD98059,
2 μM PD184352, 20 μM PD184352, 20 μM SB203580, or 20 μM
SP600125. One hour post treatment, cells weremock infected, infected
with sucrose-puriﬁed RSV at an moi of 5, or treated with 0.5 mM
sodium arsenite. One hour post infection or 30 min following arsenite
treatment, cells were harvested and analyzed for DCP1 phosphoryla-
tion using Western blot analysis as described above.
Generation and analysis of DCP1 phosphorylation mutants
A myc-DDK-tagged open reading frame DNA clone of human
DCP1a (Origene) was subjected to mutagenesis to generate constructs
in which S315, S319, T321, or all three residues (Triple) were replaced
with alanine using an Agilent Quickchange II site-directed mutagen-
esis kit, according to the manufacturer's directions. The sequences of
the mutant DDK-DCP1 cassettes were conﬁrmed by DNA sequencing.
80% conﬂuent monolayers of HEp-2 cells in 6-well plates were
transfected with 2 μg of empty-vector plasmids or plasmids encoding
GFP, wt DDK-DCP1a, or mutant DDK-DCP1a using Lipofectamine 2000
(Invitrogen) according to the manufacturer's instructions. Media were
replaced 6 h post transfection. 24 h post transfection, cells were
infected with RSV at an moi of 5. At the indicated times post infection,
either cell lysates or supernatant were harvested for Western blot or
ELISA analysis, respectively.
IL-8 quantiﬁcation
HEp-2 cells transfected with wt DDK-DCP1a or mutant DDK-
DCP1a were infected with RSV at an moi of 5 as described above
and incubated for 24 h. Cell culture supernatants were harvested
at 0, 2, 8, and 24 hpi and IL-8 concentrations were determined by
ELISA (Biolegend) by comparison to an IL-8 standard curve,
according to the manufacturer's instructions.
Immunoﬂuorescence microscopy
HEp-2 cells seeded on coverslips in 12-well plates were either
mock infected or infected with wt RSV at an moi of 5. At indicated
times post infection, cells were ﬁxed with 5% formaldehyde and 2%
sucrose in PBS for 30 min, permeabilized with 0.5% Igepal and 10%
sucrose in PBS for 20 min at 4 1C, and incubated with a rabbit
polyclonal antibody toward cellular DCP1 and a mouse mono-
clonal antibody toward RSV N protein. Following washing in PBS,
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cells were incubated with anti-rabbit AlexaFluor 488 and anti-
mouse AlexaFluor 633 (Invitrogen), as well as 406-diamindino-2-
phenylindole (DAPI). Cells were analyzed by ﬂuorescence micro-
scopy and the numbers of DCP1-containing puncta per cell were
determined using ImageJ.
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